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The N-succinylamino acid racemase/o-succinylbenzoate synthase (NSAR/OSBS) 42 
subfamily from the enolase superfamily contains different enzymes showing 43 
promiscuous N-substituted-amino acid racemase (NxAR) activity. These enzymes were 44 
originally named as N-acylamino acid racemases because of their industrial application. 45 
Nonetheless, they are pivotal in several enzymatic cascades due to their versatility to 46 
catalyze a wide substrate spectrum, allowing the production of optically pure D- or L-47 
amino acids from cheap precursors. These compounds are of paramount economic 48 
interest, since they are used as food additives, in the pharmaceutical and cosmetics 49 
industries and/or as chiral synthons in organic synthesis. Despite its economic 50 
importance, the discovery of new N-succinylamino acid racemases has become elusive, 51 
since classical sequence-based annotation methods proved ineffective in their 52 
identification, due to a high sequence similarity among the members of the enolase 53 
superfamily. During the last decade, deeper investigations into different members of the 54 
NSAR/OSBS subfamily have shed light on the classification and identification of 55 
NSAR enzymes with NxAR activity of biotechnological potential. This review aims to 56 
gather the dispersed information on NSAR/OSBS members showing NxAR activity 57 
over recent decades, focusing on their biotechnological applications and providing 58 




As for other enzymatic racemization methodologies involved in dynamic kinetic 63 
resolution (DKR) processes, the driving force boosting N-succinylamino acid racemase 64 
(NSAR)
1
 research is most likely the existence of a previous enzymatic kinetic resolution 65 
(KR) method for the production of optically pure amino acids. This KR process was 66 
                                                          
1
 We will use different acronyms (NSAR, NAAR) through the manuscript to refer to enzymes belonging 
to the N-succinylamino acid racemase/o-succinylbenzoate synthase (NSAR/OSBS) subfamily. 
already known since middle of the twentieth century [1], and takes advantage of the 67 
stereospecificity of acylases (or aminoacylases, E.C. 3.5.1.14) to produce optically pure 68 
amino acids from racemic mixtures of N-acetylamino acids (NAAs) [2, and references 69 
therein]. Evonik (Degussa) industries already manufactured L-methionine at industrial 70 
level in the 70`s using the “Acylase process” [3]. Furthermore, patents on the chemical 71 
racemization of NAAs by different companies clearly illustrate the interest to develop a 72 
chemo-enzymatic DKR before the eighties (e.g., Ajinomoto or Evonik/Degussa [4,5]). 73 
Takeda Pharmaceutical Co Ltd discovered the N-acylamino acid racemase (NAAR) 74 
activity in different microorganisms by the end of the 80’s, demonstrating a potential 75 
NAAR/acylase enzymatic tandem, also providing a new DKR approach for optically 76 
pure D- and L-amino acids [6-8]. The industrial relevance of these enzymes is clear by 77 
the extensive number of patents issued [6-43] (Table 1). 78 
 79 
To the best of our knowledge, the first paper dealing with an NSAR enzyme was not 80 
published until the 90s. Tokuyama’s group described NAAR activity in some 81 
actinomycetes strains belonging to the genus Streptomyces, Actinomadura, 82 
Actinomyces, Jensenia, Amycolatopsis and Sebekia. However, they did not find this 83 
activity in other bacteria, yeasts or fungi, from more than 44000 strains tested [44,45]. 84 
From the organisms described in that work, enzymes belonging to Streptomyces atratus 85 
Y-53 (SatNSAR) [46], Sebekia benihana (SebeNSAR) [22-24] and Amycolatopsis [47-86 
49] were characterized and used (Table 1). Whereas the principal interest of these 87 
enzymes was the racemization of NAAs, their ability to racemize different N-88 
substituted-amino acids (NxAs) was also soon reported, showing them to be active 89 
towards N-acetyl (NAAs), N-carbamoyl (NCAs), N-chloroacetyl (NChAs), N-butyril 90 
(NBtAs), N-propionil (NPrAs), N-benzoyl (NBzAs) or N-formyl-amino acids (NFAs), 91 
among others [46,47]. Despite the potential DKR application of these enzymes, only a 92 
discrete number of NAAR enzymes were identified and/or characterized in the 93 
following years, mainly from Amycolatopsis and Deinococcus genus, mostly boosted by 94 
their industrial interest [25, 50-53, see also Table 1] or for structural characterization 95 
[54,55]. Additional actinomycetes strains were shown to possess NAAR activity, 96 
although no further information has been reported on the enzymes from these 97 
microorganisms [56]. NSAR was already shown to be a member of the functional 98 
diverse enolase superfamily before the beginning of the new millennium [51]. Several 99 
works at the beginning of the 21
st
 century focused on deciphering the natural function of 100 
NSARs and some evolutionary aspects [51,57,58, 69-76] (see below), allowing to 101 
localize new NSARs in Bacillus/Geobacillus genera. Some of the NSARs belonging to 102 
this genera have been highly characterized and/or applied to the production of optically 103 
pure amino acids [27-38,59,61-68]. A different N-succinyl arginine/lysine racemase 104 
from Bacillus cereus ATCC 14579, highly specific for NS-Arg and NS-Lys has been 105 
reported, although it does not belong to the NSAR group reviewed in this paper [59]. 106 
The characterization of an NSAR from Chloroflexus aurantiacus (CauNSAR) [26] and 107 
the determination of the crystal structure of Thermus thermophilus NSAR (TteNSAR) 108 
[60], further expand the organisms in which NSAR activity has been found. Finally, 109 
Exiguobacterium, Lysinibacillus, Roseiflexus, Enterococcus or Listeria genera have also 110 
been reported to present NSAR activity, although they have been studied in less detail 111 
from the biotechnological point of view [72-74] 112 
 113 
Natural function and evolutionary aspects on NSAR enzymes  114 
 115 
After one decade using the industrially-biased NAAR nomenclature, Gerlt’s group gave 116 
an important step towards understanding the natural function of NSAR, suggesting that 117 
the “correct” function of Amycolatopsis sp. TS-1-60 NAAR (AmyNSAR) was the o-118 
succinylbenzoate synthase (OSBS) reaction in menaquinone biosynthesis [51], due to 119 
the sequence similarity to Bacillus subtilis OSBS. The NAAR activity was suggested as 120 
a secondary and promiscuous activity of OSBS, with no impact on the organism in its 121 
metabolic niche (Figure 1). Despite the significance of this work in the comprehension 122 
of the promiscuous NSAR activity, the NAAR nomenclature continued to be used for 123 
several years in the literature. Another milestone in the understanding of the function of 124 
NSAR enzymes was achieved in 2006 [57]. Geobacillus kaustophilus was shown to 125 
contain a member of the enolase superfamily with NSAR activity (GkaNSAR), 126 
homolog to the well-characterized enzymes from Amycolatopsis. GkaNSAR was 127 
encoded in a new gene cluster, different to the menaquinone biosynthesis operon in 128 
which OSBS is included [51] (Figure 2). A similar cluster was identified for 129 
Amycolatopsis and Thermus genera [57] (Figure 2). After two decades of the discovery 130 
of NSARs, the authors concluded that GkaNSAR constitutes part of a novel, irreversible 131 
pathway for the conversion of D- to L-amino acids (Figure 2, lower panel), different to 132 
the previously proposed menaquinone biosynthesis [51]. Since i) this enzyme was 133 
functionally promiscuous, also catalyzing efficiently the OSBS reaction, and ii) no other 134 
potential OSBS was encoded in the menaquinone operon or elsewhere in the genome, 135 
the authors raised the possibility that the NSAR is a bifunctional enzyme rather than an 136 
accidentally promiscuous enzyme, as previously suggested [51]. The nomenclature 137 
OSBS/NSAR subfamily was proposed, due to the probable overlapping activity of both 138 
enzymes. A seminal and must-read paper by Glasner et al. on the evolution of the 139 
OSBS/NAAR subfamily showed that NSARs of known activity were phylogenetically 140 
included under the so-called Firmicutes OSBS/NSAR subfamily (Figure 3), together 141 
with other enzymes for which NSAR activity could not be detected [58]. This work 142 
showed the complex scenario of functional evolution in this subfamily, and helps 143 
explaining why only a discrete number of biotechnologically relevant NSAR enzymes 144 
had been discovered by that time, since sequence-based approaches also identified 145 
OSBS enzymes not necessarily containing NSAR activity (see below).  146 
 147 
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Dr Reddy's Lab/Univ. of Edinburgh. (a) Refers to JP-A-2007-82534 and 2008-61642 JP, but we could not obtain the corresponding 150 
documents.  151 
Patent No. Description Pub. year Organism Ref 
EP0304021A2  Acylamino acid racemase, production and use thereof 1 1989 S. atratus, NSAR-producing microorganisms   [6] 
JPH01137973A Acylamino acid racemase, its production and use1 1989 S. atratus [7] 
US4981799A Acylamino acid racemase, production and use thereof1 1991 S. atratus [8] 
CN1035320A Acylamino acid racemase and its use1 1989 NSAR-producing microorganisms  [9] 
JPH06205668A Bacteria producing acylamino acid racemase1 1994 Amycolatopsis sp.  [10] 
EP0474965A2* DNA encoding acylamino acid racemase and its use1 1992 S. atratus, Amycolatopsis sp.  [11] 
US5525501A* DNA Fragment encoding acylamino acid racemase1 1996 S. atratus  Amycolatopsis sp.  [12] 
CA2038202A1* DNA and use thereof1 1992 Amycolatopsis sp.  [13] 
JP3066473B2* DNA and its applications1 2000 Amycolatopsis sp.  [14] 
DE10050123A1 A process for the production of amino acids2 2002 Amycolatopsis orientalis  [15] 
US6656710B2 Process for the production of amino acids using racemase and acylase2 2003 S. atratus,  Amycolatopsis sp. and orientalis  [16] 
DE10050124A1 Using the acetylamino from Amycolatopsis orientalis racemization of carbamoylamino2… 2002 Amycolatopsis orientalis  [17] 
EP1074628 A1# N-Acetylamino acid racemase2 2001 Amycolatopsis orientalis  [18] 
JP2001046088A# N-acetylamino acid racemase, its coating gene, plasmid, vector and microorganism… 2001 Amycolatopsis orientalis [19] 
US6372459B1# N-acetyl amino acid racemase2 2002 Amycolatopsis orientalis  [20] 
US20070148742A1 Process for the production of amino acids2 2007 S. atratus, Amycolatopsis sp. and orientalis [21] 
EP1130108A1& Methods for racemizing N-acylamino acids and producing optically active amino acids3 2001 Se. benihana [22] 
US6664083B2& Methods for racemizing N-acylamino acids and producing optically active amino acids3 2003 Se. benihana [23] 
JP2001314191A& Method for racemization for n-acylamino acid and method of production for optically active amino acid3 2001 Se. benihana [24] 
JP2002238581A N-acylamino acid racemase gene and its usage3 2002 Deinococcus radiodurans  [25] 
JP2007082534A Heat-stable N-acylamino acid racemase, method for producing the same and application thereof4 2007 Chloroflexus aurantiacus [26] 
JP2008061642A Method for producing D-amino acid4 2008 G. stearothermophilus  [27] 
WO2010050516A1@ Method for producing L-amino acid5 2010 G. kaustophilus, T. thermophilus  [28] 
EP2351848B1@ Method for producing L-amino acid5 2011 G. kaustophilus, T. thermophilus  [29] 
JP5744521B2@ Method of manufacturing a L-amino acid5 2015 G. kaustophilus, T. thermophilus  [30] 
JP2015091265A@ Method for producing L-amino acid5 2015 G. kaustophilus, T. thermophilus  [31] 
US9464306B2@ Method for producing L-amino acid5 2016 G. kaustophilus, T. thermophilus  [32] 
JP2008307006A Method for producing L-amino acid6 2008 G. stearothermophilus  [33] 
US20110244530A1 L-succinylaminoacylase and process for producing L-amino acid using it7 2011 G. stearothermophilus  [34] 
US8728771B2 L-succinylaminoacylase and process for producing L-amino acid using it7 2014 G. stearothermophilus, C. aurantiacus [35] 
WO2010067613A1 L-succinylaminoacylase and process for producing L-amino acid using same7 2010 G. stearothermophilus, C. aurantiacus [36] 
WO2018088434A1 Method for producing N-succinyl-hydroxy-D-amino acid and/or hydroxy-D-amino acid  2018 G. stearothermophilus, C. aurantiacus [37] 
WO2009136500A1 L-succinyl aminoacylase and process for producing an L-amino acid using the same7 2009 G. stearothermophilus  [38] 
JP6048850B2 D- succinylase, and method for producing D-amino acids using the same7 2015 (a) [39] 
WO2012002450A1 D-succinylase, and method for producing D-amino acid using same7 2012 (a) [40] 
US20030059816A1 Methods for identifying racemases9 2003 (a) [41] 
US20080003640A1 Deinococcus N-acylamino acid racemase and use of preparing L-amino acid10 2009 Deinococcus radiodurans NCHU1003 [42] 
WO2012140507A1 Production of enantiomerically purified amino acids11 2012 Amycolatopsis sp. TS-1-60 NAAR/ Double mutant [43] 
 152 
Figure 1. OSBS (A) and NSAR (B) activities catalyzed by different members of the 153 
NSAR/OSBS subfamily. N-Succinyl-amino acids (R=succinyl) are likely to be the 154 
biologically preferred acyl group [57]. It is important to highlight the similarity between 155 
a succinyl-group and the 3-carboxypropionyl group in SHCHC. C) General strategy 156 
proposed for abstraction of the α-protons of carboxylic acids by the enolase 157 




















Figure 2. Gene clusters containing NSAR/OSBS members [57,74]. Those clusters from 178 
a different strain to the one where NSAR has been reported are marked with an asterisk 179 
(*). Amycolatopsis azurea (AY271627), Amycolatopsis mediterrani S699 (G0FPT7), 180 
Geobacillus kaustophilus HTA426 (NC_006510.1), Thermus thermophilus HB8 181 
(NC_006461.1), Roseiflexus castenholzii HLO8 (NC_009767.1), Lysinibacillus varians 182 
GY32 (NZ_CP006837.1), Geobacillus stearothermophilus str. 10 (NZ_CP008934.1), 183 
Streptomyces atratus OK807 (NZ_FPJO01000025.1), Deinococcus radiodurans R1 184 
(AE000513.1), Chloroflexus auranticus Y-400-fl (NC_012032.1), Listeria innocua 185 
Clip11262 (NC_003212.1). Abbreviations are as follows: M20: M20 peptidase 186 
superfamily. AH: amidohydrolase superfamily. GNAT: member of the GNAT N-187 
acetyltransferase superfamily. α/β: α/β hydrolase superfamily member (probably same 188 
function as M20 [74]). MetPhos: metallophosphoesterase. $: tRNA-lysine. GPC: 189 
Glutaminyl peptide cyclotransferase; FKBP: FKBP-type peptidyl-prolyl cis-trans 190 
isomerase; LytR: Sensory transduction protein LytR; WecA: UDP-N-191 
acetylglucosamine-undecaprenyl-phosphate N-acetylglucosaminephosphotransferase. 192 
Lower panel schematically shows the irreversible pathway for the conversion of D- to 193 
L-amino acids discovered in G. kaustophilus HTA426 [57]. Phenylalanine is given as 194 
an example, but the reader is pointed to [57] where a comprehensive study on the 195 
different substrates for the different enzymes in this route was conducted. 196 
After deciphering the natural function of NSAR, huge efforts have been paid on finding 197 
the molecular determinants allowing the evolution of the OSBS family and to 198 
understand the substrate promiscuity of NSAR/OSBS enzymes [69-74]. Protein 199 
Engineering of NSAR [75,76] and the development/improvement of the 200 
biotechnological applications of NSARs have also been pursued [63,66,67]. Studies 201 
focused on the Pro18-Gly24 loop (known as 20s loop, see below) of AmyNSAR, which 202 
flaps upon substrate binding, confirmed its essential character for achieving biologically 203 
relevant NSAR and OSBS activity levels [71]. However, studies on the counterpart loop 204 
in different members of the enolase superfamily suggest a complex picture to fully 205 
understand the molecular determinants guiding enzyme activity in the superfamily. Its 206 
divergence contributes not only to the specificity of the activities of the superfamily, but 207 
also suggests different roles in the context of different enzymes of the family [70,71]. 208 
The origin of the promiscuous NSAR activity was placed near the base of the 209 
NSAR/OSBS subfamily tree [72], and thus, it is advisable to look for new NSAR 210 
enzymes in this subgroup. Different OSBS/NSAR subfamily members with NSAR 211 
activity have been identified, such as those from Exiguobacterium sp. AT1b OSBS 212 
(ExiOSBS) [72], Enterococcus faecalis V583 (EfaNSAR), Listeria innocua (LinNSAR) 213 
[73], Lysinibacillus varians GY32 (LvaNSAR), Roseiflexus castenholzii HLO8 214 
(RcaNSAR) and Amycolatopsis mediterranei S699 (AmedNSAR) [74]. On the other 215 
hand, the OSBS/NSAR subfamily also contains OSBS enzymes with no apparent 216 
activity with NAAs, such as Bacillus subtilis YtfD
2
 or Staphylococcus aureus 217 
[51,73,74]. The same occurs for the recently described OSBS from Alicyclobacillus 218 
acidocaldarius (AacOSBS), for which a modest NSAR activity was engineered by a 219 
single mutation [74]. In addition, it has been suggested that several species into the 220 
Firmicutes subfamily have obtained the NSAR/OSBS gene by lateral gene transfer [72]. 221 
The difficulties to find new NSARs would explain why in more than 30 years from their 222 
discovery, mainly the NSARs from Amycolatopsis and Bacillus/Geobacillus have been 223 
profoundly studied and exploited (Table 1, [10-21,27-38,43,47-53,55,64-68]). 224 
Deinococcus, Streptomyces, Thermus and Chloroflexus enzymes have also found 225 
discrete applications in the biotechnological field (Table 1, [7,8,11,12,16,21,25,26,28-226 
                                                          
2
 This enzyme shares more than 40 % of sequence identity with NSARs of proved 
activity, although it has been suggested -but not experimentally demonstrated - that it 
might have activity with other NxAs, since it only was checked with an NAA substrate 
[72]. 
32,35-37,42]). While Exigobacterium [72], Lysinibacillus, Roseiflexus, Enterococcus or 227 
Listeria OSBS/NSAR enzymes have been reported to exhibit NSAR activity [73,74], 228 
we could not find any information on whether these enzymes recognize other NxAs; the 229 
substrate promiscuity of these enzymes needs to be further studied. Finally, the genome 230 
sequences of some microorganisms for which NAAR activity has been detected are 231 




Figure 3. Phylogenetic tree of the OSBS family, showing the division into eight major 236 
subfamilies, one of them being the OSBS/NSAR subfamily where the NSAR activity 237 
seems to be confined. The reader is referred to [58,69,71,72,74] for deeper insights into 238 
the phylogeny of these enzymes "Reprinted with permission from [69]. Copyright 2012. 239 
American Chemical Society". 240 
 241 
At this point, the reader interested in NSARs with biotechnological potential should 242 
understand the difficulties of sequence-based identification of new NSARs. As already 243 
highlighted by the numerous works by Gerlt and Glasner, besides the different 244 
nomenclature used for these enzymes in the literature, two specific difficulties persist to 245 
find new NSARs. Firstly, since different members of the NSAR/OSBS subfamily where 246 
NSAR activity is found do not present this promiscuous activity, and they do not 247 
constitute a separate clade, it is complicated to predict NSAR activity from sequence 248 
similarity alone (Figure 3) [58,69,70,72]. As previously mentioned, no activity towards 249 
NxA has been found within members of this subfamily (Bacillus subtilis or 250 
Staphylococcus aureus [51,73,74]; ExiOSBS shows inefficient NSAR activity [72,74] 251 
and AacOSBS does not present activity towards NS-PheGly [74]). Secondly, several 252 
works have proved the difficulties to find the determinant allowing the evolution of 253 
OSBS family towards NSAR activity [70,71,74]. NSAR activity thus appears to be a 254 
recent evolutionary event towards new metabolic activities such as the interconversion 255 
of D- to L-amino acids for Geobacillus kaustophilus, which to date seems to be 256 
confined principally to enzymes in the Firmicutes NSAR/OSBS subfamily [57,58,74]. 257 
Odokonyero et al. also highlights that in some cases OSBS activity is a promiscuous, 258 
nonbiological side reaction, while NSAR (or another activity, which is yet to be 259 
determined) is the primary biological function [74]. The later hypothesis is supported by 260 
gene clusters such as those found in Chloroflexus auranticus or Listeria innocua (Figure 261 
2). With these difficulties in mind, we might argue that new NSAR could be found in a 262 
gene cluster similar to that found in G. kaustophilus, different to the classical 263 
menaquinone biosynthesis operon. Clusters where OSBS/NSAR enzymes appear near a 264 
GNAT and/or a M20 superfamily member seem the more reasonable locus to look for 265 
new enzymes with biotechnological applications (Figure 2, see also [51,58,74]). 266 
 267 
Enzymatic properties of NSARs 268 
NSARs have been successfully purified from wild-type organisms [46,47] or 269 
overexpressed/purified from recombinant organisms [48-55,57-75]. Members from the 270 
NSAR/OSBS subfamily have been described as dimers (Enterococcus, Listeria), 271 
tetramers (Geobacillus), hexamers (Streptomyces) or octamers
3
 (Amycolatopsis, 272 
Deinococcus, Thermus, Sebekia) (Table 2). The different quaternary structures of 273 
proteins in the enolase superfamily have been suggested to be associated to the 274 
evolutionary rate of this superfamily; whereas monomeric members of the superfamily 275 
evolved rapidly, the NSAR/OSBS subfamily has been suggested to evolve at a slower 276 
rate than other monomeric OSBS subfamilies, since retention of higher-order quaternary 277 
                                                          
3
 The Molecular masses reported in the corresponding literature for Sebekia and Thermus do not 
correspond to octamers, but to higher oligomeric species.  
structure caused them to retain structural characteristics similar to many of the families 278 
in the enolase superfamily [73]. The optimum pH of the enzymes characterized at some 279 
detail is found centered in the range 7.5-8.0 (Table 2); optimum temperatures range 280 
from 30 °C (Amycolatopsis orientalis) to 60-70 °C (Geobacillus and Deinococcus 281 
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Table 2. Biochemical properties of NSARs from different sources. ND: not determined. 283 
EDTA: ethylenediaminetetraacetic acid; PCMB; p-Chloromercuribenzoate; PHMB: p-284 
Hydroxymercuribenzoate. HQSA: 8-hydroxyquinoline 5-sulfonic acid; SH:  Salicyl 285 
hydroxamate; β-ME: β-mercaptoethanol; DTT: dithiothreitol; MalNEt: N-286 
Ethylmaleimide. IAc: iodoacetate. In those cases in which the optimal conditions were 287 
not calculated, the numbers in parentheses represent the condition used to asses enzyme 288 
activity.* 100% sequence identity with Deinococcus radiodurans NCHU1003 NSAR, 289 
characterized in [42]. 290 
 291 
The metalloenzyme character of NSAR is clear since its activity is altered in the 292 
presence of metal ions and inhibited by chelating reagents (Table 2). Co
2+
 has shown to 293 
be the best cofactor for a vast majority of NSARs (Table 2). However, since metal 294 
inhibition at high metal concentrations has been observed, cofactor concentration-295 
dependence needs to be assayed to optimize enzyme activity. As way of example, Co
2+
 296 
showed the best performance at 1 mM with SatNSAR, whereas the activity dropped 297 
when using 10 mM of this cation. On the other hand, no inhibition was observed when 298 
using up to 10 mM MnCl2, but the activity was slightly lower than with 1 mM Co
2+
 299 
[46]. Other OSBS/NSARs have been scarcely described, such as AmedNSAR, 300 





 as cofactors, at pH 8.0 and 25º C, but the optimal 302 
conditions were not characterized. Similarly, the enzyme from G. stearothermphilus 303 
NCA1503 was used with Co
2+
, at pH 7.5 and 37 ºC [79,80]. The effect of sulfhydryl 304 
reagents has also been well documented [46,47,52,53,64]. However, no Cys residue has 305 
been identified to be involved in the activity of the enzyme, nor do disulfide bridges 306 
seem to be necessary for protein folding [54,55,60]. On the other hand, we want to 307 
highlight the presence of a totally conserved cysteine residue preceding the metal-308 
binding residue D239 (Cys237 in AmyNSAR; Figure 4), but we cannot ascertain 309 
whether this residue is responsible for the effect of sulfhydryl reagents. A deeper 310 
characterization of Geobacillus NSARs has been conducted [57,64,65,68]. Co
2+
 311 
addition produced an enzyme stabilization of approximately 10-15 ºC [65,68]. 312 
Interestingly, the apparent thermal denaturation midpoint (Tmapp) for G. 313 
stearothermophilus CECT 49 NSAR (GstNSAR) was 77.0 ºC, higher than the thermal 314 
midpoint calculated from the residual activity after preincubation, showing gradual loss 315 
of activity at preincubation temperatures over 50-60 ºC [65,68]. These differences could 316 
be explained by the equilibrium model: enzymatic activity might be lowered or lost 317 
below the apparent unfolding temperature as a result of temperature-induced 318 
conformational changes at the active site from an optimum configuration for substrate 319 
binding to a less optimum one [81,82]. This conjecture is in agreement with the 320 
expected flexibility of a promiscuous active site, and is further supported by quantum 321 
mechanics/molecular mechanics (QM/MM) analysis in the case of NSAR [83]. 322 
 323 
NSAR Substrates recognized Not recognized Ref. 
Streptomyces 
atratus Y-53 
NAAs (D- & L-): Met, Ala, Leu, Phe, Trp, Val; 
NFAAs (D- & L-): Met; NChAAs (D- & L-): Phe, Val 
AAs (D- & L-): Met, 





NAAs (D- & L-): Met, Ala, Leu, Phe, Trp, Val;  NA-
D-Phegly, NA-D-Napala, NA-L-Tyr; NChAAs (D- & 
L-): Phe, Val; NCh-L-Leu; NFAA (D- & L-): Met; 
NPrA (D- & L-): Met; NBtA (D- & L-): Met; NSAs 
(D- & L-): Met, PheGly; NBz-D-Ala; NC-D-Met; L-
Ala-L-Met 










NAAs (D- & L-): Met, Phe, Val; NAAs (D-): Ala, 







NAAs (D- & L-): Met, Tyr, Val, Leu, Phe, Ala; NAAs 










NSAs (L-): Ala, Val, Leu, Ile, Met, Phe, Tyr, Trp, Ser, 









NAAs (D- & L-): Met, Phe, Trp, Ala, Asn; NCAs (D- 
& L-): Met, ABA, Norval, NorLeu, HPhe; NSAs (D- & 
L-): Ala, Phe; NFAs (D- & L-): Met, Ala, Trp, ABA, 
NorLeu, PheGly, ethionine, HPhe;  
 





NSAs (D- & L-): Phe ; NAAs (D-): Met; NCAs (D-): 
Met, NorLeu; NFAAs (D- & L-): Met, Norleu, ABA, 





NSAs (racemic): Phe, Trp;  NSAs (L-): Phe, Val, Ser, 
Trp; NAAs (L-): Phe   
 




NAAs (D- & L-): Met, Phe; NAAs (L-): Gln, Leu, Trp; 
NChAAs ( L-):  Phe 
NAAs (L-): Arg, Pro, 
Lys, His; NAAs (D-): 





NS-D-Phe,  NS-L-Phe; NF-D-Met, NF-D-Norleu;    





NAAs (D- & L-): HPhe; NCAs (D- & L-): HPhe; 
NCAs (L-): Gly, Ser, Ala 






N-ac-D-Met; NSAs (racemic): 4-Br-Phe, Phe, 3-F-Phe, 








Table 3. Substrate promiscuity of different NSARs. NSA: N-succynil-amino acids; 325 
NAA: N-acetyl-amino acids. NFA: N-formyl-amino acids. NCA: N-carbamoyl-amino 326 
acids. NChA: N-chloroacetyl-amino acids. NPrA: N-propionil-amino acids: NBtA: N-327 
butyril-amino acids. NBz; N-benzoyl-amino acids. NM: N-Methyl-. ABA: 2-328 
aminobutyric acid. Phegly: phenylglycine. Napala: naphtylalanine. tertLeu: Tert-329 
leucine; Norleu: norleucine; Norval: norvaline; HPhe: homophenylalanine. 3-F-ophe, 330 
2iGly: 2-indanyl-Gly. 6hGly: 6-heptenyl-Gly.    331 
 332 
Besides the “natural” NSAs racemization, the activity towards different NAAs, NCAs, 333 
NChAs, NBtAs, NPrAs, NBzAs or NFAs has been shown (Table 3). NSARs have also 334 
been shown to racemize N-succinyl-hydroxy-L-amino acids [37] or L-Ala-L-Met [47]. 335 
Besides the enzymes presented in Table 3, RcaNSAR, LvaNSAR, AmedNSAR, 336 
AacOSBS (Y299I mutant), EfaNSAR, LinNSAR and ExiOSBS are active towards NS-337 
D- or NS-L-PheGly [72-74] (Table 4). 338 
 339 
Table 4. Catalytic efficiencies shown by NSAR with different NxAs for which kinetic 340 
parameters have been studied at some detail. HPhe: homophenylalanine. PheGly: 341 
phenylglycine. 
$
 strain CECT4264. 342 
  343 
Few studies have reported detailed kinetic and affinity parameters of NSARs towards 344 
different NxAs (Table 4). The best NxA substrate found to date for an NSAR yields 345 








(NS-PheGly, Table 4). We 346 









range with different NFAs, similar to the natural NSA substrates [65,68]. Our 348 









, Table 4), and its use might be advantageous in some cases. Apart from these 350 








































































biochemical studies, most of the reports on NSAR substrate promiscuity only report the 351 
percentage of the activity of NSARs towards different D- and L-NxAs [45-352 
47,50,52,53,54]. From these values, no clear preference of NSARs for one of the 353 
enantiomers could be ascertained (e.g., the relative activities for SatNSAR and 354 
AmyNSAR were NA-L-Met > NA-D-Met, but NA-D-Val > NA-L-Val [46,52]). No 355 
clear conclusion can neither be extracted from the biochemical parameters on different 356 
NSARs towards the D- or L-enantiomers [65,68,78]. Binding studies conducted with 357 
GstNSAR mutants showed also slight -but not conclusive- preference for D-NFAA 358 
binding [68]. Whereas this slight preference towards D-enantiomers would agree with 359 
the expected enantioselectivity of an NSAR participating in the irreversible conversion 360 
of D-amino acids to their L-enantiomers [57], we believe that the experimental data 361 
available does not allow formulating a general conclusion on NSAR enantioselectivity. 362 
 363 
Structural features of NSARs 364 
The first X-Ray structure of an NAAR belonged to the Deinococcus genus (DraNSAR) 365 
[54], although the structure from AmyNSAR was reported almost simultaneously [55]. 366 
Before these X-Ray structures were deciphered, different structural aspects of NSARs 367 
were experimentally determined. The metal-dependence of NSARs was reported in the 368 
mid-90s [46,47]. Classification into the enolase superfamily was proposed by the end of 369 
the millennium [51]. Sequence comparisons of different members of the enolase 370 
superfamily suggested the role of three carboxylate groups from Asp/Glu residues in the 371 
metal-binding site [53,77], which were initially incorrectly assigned for AmyNSAR 372 
[48]. Based on the sequence similarity to other members of the superfamily, Lys163 373 
was suggested as a catalytic residue [48] (Figure 4). In a seminal work on the residue 374 
conservation of the enolase superfamily, two bases (Lys163 and Lys263) were proposed 375 
in the active site of NSAR as responsible for catalysis [77]. The existence of a KXK 376 
motif containing the (S)-specific base was highlighted in different members of the 377 
enolase superfamily; it appears to be diagnostic of the presence of functional groups that 378 
are involved as electrophilic and general basic catalysts, respectively. Mutagenesis 379 
studies supported the two-base mechanism for racemization [51,78].  380 
 381 
Figure 4. Sequence alignment of OSBS/NSAR enzymes with biotechnological potential 382 
generated with the Espript software [101], using BioEdit to generate the alignment used 383 
as input, together with the secondary structure of AmyNSAR (PDB ID 1SJA, chain A 384 
[55]). GenBank accession numbers available are indicated into bracket following to the 385 
corresponding organism. AmyNSAR, Amycolatopsis sp. TS-1-60, (BAA06400) [48]; 386 
Ammedit, Amycolatopsis mediterrani S699, (WP_013225317.1) [51,74]; AmorNSAR, 387 
Amycolatopsis orientalis subspecies lurida, (CAC00653) [52]; AmazNSAR, 388 
Amycolatopsis azurea, (AF335269_1) [53]; GkaNSAR, Geobacillus kaustophilus 389 
HTA426, (WP_011230427) [51,57]; Gka4NSAR, Geobacillus kaustophilus 390 
CECT4264, (ABZ81711) [64]; GstNSAR, Geobacillus stearothermophilus CECT49, 391 
(identical to WP_021321420)  [68]; Gst1NSAR, Geobacillus stearothermophilus 392 
NCA1503, (BAT31602.1)  [80]; DraNSAR, Deinococcus radiodurans ATCC 13939, 393 
(1R0M) [54], Dra8NSAR, Deinococcus radiodurans CECT833, (identical to 394 
WP_010886692) [68]; SatNSAR, Streptomyces atratus Y53, (WP_072488525) [46,51]; 395 
SebeNSAR, Sebekia benihana IFO 14309, (extracted from [23]); CauNSAR, 396 
Chloroflexus aurantiacus (WP_012256750) [35]; TteNSAR, Thermus  thermophilus 397 
HB8, (BAD70697.1) [28,60]; LiNSAR, Listeria innocua Clip11262 398 
(WP_010991324.1); RcaNSAR, Roseiflexus castenholzii HLO8 (WP_012120942.1); 399 
EfaNSAR, Enterococcus faecalis V583, (WP_002387683.1); LinNSAR, Lysinibacillus 400 
varians GY32 (WP_025220731.1). The residues at binding distance of NAA in the 401 
catalytic pocket of AmyNSAR are marked (PDB IDs 1SJA; C: carboxyl group-binding 402 
site; W: water-mediated binding to C; M: metal-binding site; S: side-chain-binding 403 
region; N: N-acetyl moiety binding residues). Additional residues within binding 404 
distance of NSA in PDB ID 1SJC are also marked (*). The highly conserved Cys 405 
residue in NSAR is also marked (#). 406 
 407 
X-Ray structures of NSAR/OSBS subfamily members are available from Deinococcus 408 
(DraNSAR, PDB IDs 1ROM, 1XS2, 1XPY) [54], Amylocaptosis (AmyNSAR, PDB IDs 409 
1SJA, 1SJB, 1SJC, 1SJD, 4A6G, 5FJO, 5FJP, 5FJR, 5FJU, 5FJT) [55,75 and Sanchez-410 
Carron et al., unpublished results], Thermus (PDB ID 2ZC8) [60], Enterococcus (PDB 411 
ID 1WUE) [73] and Listeria (PDB ID 1WUF) [73], confirming the enolase fold. We 412 
have also recently solved the structure from GstNSAR at 2.8Å (to be published). The 413 
DraNSAR and AmyNSAR structures are those which have been studied in higher detail.  414 
 415 
NSAR monomers are composed of a mixed α/β capping domain and a central (β/α)7β 416 
barrel domain [54] (Figure 5A). Initial inspections of the DraNSAR structure revealed 417 
the existence of a disordered loop between two β-strands (residues 24-33 in PDB ID 418 
1R0M, 20s loop), with a proposed role in ligand binding (Figure 5A). Metal-bound 419 
structure confirmed the residues involved in metal binding, where a single Mg
2+
 cation 420 
is present in each monomer, coordinated by Asp195, Glu220, Asp245 (Figure 4). The 421 
Lys170-Asp195-Glu220-Asp245-Lys269 framework was also identified as responsible 422 
for catalyzing a putative 1,1-proton exchange of NAA. The essentiality of a common 423 
catalytic platform was reflected by the conservation of this framework in different 424 
enolase superfamily members, enabling these enzymes to share the common ability to 425 











Figure 5. A) Monomeric structure of DraNSAR showing the two domains forming the 437 
overall architecture (PDB ID 1XPY; cap domain (green) and catalytic domain (orange). 438 
The relative position of the catalytic site, containing the Lys170-Asp195-Glu220-439 
Asp245-Lys269 framework, is shown in stick mode. The catalytic cation is shown as a 440 
light blue sphere. The 20s (red) and 50s (blue) loops are also shown. B) Superposition 441 
of Mg
2+
- (PDB ID 1XS2, yellow) and Mg
2+
/NA-L-Gln (PDB ID 1XPY, green, ligand 442 
shown as sticks) bound DraNSAR [54]. Clamp-like movements of the catalytic domain 443 
account for ligand-fitting.  444 
 445 
DraNSAR undergoes ligand induced-fit movement upon substrate binding (Figure 5B), 446 
showing the catalytic domain approaching to the cap domain, with a difference of 447 
approximately 15º. In the bound structure, the flexible 20s loop in the cap domain is 448 
well defined, demonstrating its key role in enzyme activity. Furthermore, the differences 449 
observed in the catalytic domain upon structure superposition (Figure 5B) most likely 450 
indicate that it can approach the lid domain thanks to the interaction with the 20s loop. 451 
The NAA-bound structures from DraNSAR (PDB ID 1XPY [54]) and AmyNSAR 452 
enzymes (PDB ID 1SJA [55]) provide different ligand-binding information: whereas the 453 
ligands occupy approximately the same position, the NA-Gln fitted in structure 1XPY 454 
appears “rotated” with respect to the ligands fitted in AmyNSAR (specifically, NA-Met 455 
50s loop 
20s loop 
A) B) Cap domain 
Catalytic domain 
in PDB ID 1SJA, Figure 1SM)
4
. In the NA-Met-bound AmyNSAR structure, the 456 
carboxylate moiety of the substrate is at binding distance of Lys161, Lys163, Lys263 457 
and the cation in the metal-binding site. The methionine side chain of the NA-Met 458 
substrate is encompassed by groups Phe23, Met 50, Asn191, Met292 and Ile293; the N-459 
acetyl-moiety is placed in the environment of Phe19, Ser135 and Gly291 (PDB ID 460 
1SJA) [55] (Figure 6A). Despite no clear interactions of the substrate with these 461 
residues, Gly291 and two additional conserved residues (Asn261 and Asp316) bind to 462 
water molecules bridging the carboxylate moiety of the substrate (Figure 4, Figure 6A). 463 
Besides a displacement of the ligand with respect to NA-Met, the structure bound to 464 
NS-Met (PDB ID 1SJC) reveals interactions with the longer succinyl-moiety, some of 465 
which also involve water-bridging molecules (e.g. water molecules bound to Glu294, 466 
Arg299, or Asp316; Figure 6A). The additional interactions would explain the 467 
preference for the natural NSA substrate [55]. Despite the modest resolution of the 468 
corresponding structures, superposition of different substrate-bound WT and mutant 469 
AmyNSAR structures reveal notable differences in cation and ligand positioning 470 
(Figure 6B) with only slight changes in the catalytic center residues. The rearrangement 471 
observed in the 20s loop as a result of substrate-induced fit supports its role in substrate 472 
binding. Mutation of residues in the 20s loop suggested its importance in enzyme 473 
activity and substrate binding [71]. Deletion of residues 18-26 decreased the efficiency 474 
of OSBS and NSAR activities by 4500-fold and 25000-fold respectively, although the 475 
efficiency of this mutant was still well above the rate of non-catalyzed reactions. The 476 
largest effect of a single mutation in the region 18-24 was the F19A mutation, 477 
decreasing 200-fold and 120-fold its OSBS and NSAR efficiency, respectively [71]. 478 
The authors suggested hydrophobic interactions between Phe19 and the substrate as 479 
responsible for the changes observed. Mutation of other two residues which side chains 480 
are facing the catalytic center (Thr21 and Phe23) also resulted in lower KM values and 481 
altered kcat values. The three residues are near Lys163, and their mutation could affect 482 
the positioning of this catalytic residue, affecting enzyme activity. Phe19 is also in 483 
contact with Ser135 and Phe323, which bind to the substrate. Phe23 is near of the tip of 484 
the 20s loop, and interacts with Tyr55, Asn191, and the substrate.  485 
                                                          
4 
Taking into account the availability of other more recent AmyNSAR ligand-bound structures (e.g., PDB 
IDs 4A6G or 5FJP) and that the electronic density maps corresponding to DraNSAR-bound structure are 
not available (PDB ID 1XPY), the fitting of AmyNSAR is used in this review to identify the residues 
involved in ligand binding. In this sense, it is possible that the side chain-binding region might be 




Figure 6. A) Superposition of NA-Met- (PDB ID 1SJA, orange) and NS-Met-bound 489 













catalytic pocket are shown. Metals are shown as spheres, and water molecules as 491 
crosses. B) Superposition of different AmyNSAR-bound structures showing the 492 
differences in substrate and metal positioning. NA-Met (PDB ID 1SJA, red), o-493 
succinylbenzoic acid (PDB ID 1SJB, green), NS-Met (PDB ID 1SJC, blue), NS-PheGly 494 
(PDB ID 1SJD, yellow), NA-Met (PDB ID 4A6G, G291D/F323Y mutant, violet) and 495 
NA-naphtylalanine (PDB ID, G291D/F323Y/I293G mutant, cyan). Metals are shown as 496 
spheres, and water molecules as crosses. 497 
 498 
Mutation of two surface-exposed residues (Arg20 and Ser22) thought to assist in 20s 499 
loop closure through interaction with the cap domain, also resulted in decreased KM 500 
values, although their kcat were only slightly affected [71]. Finally, QM/MM analysis 501 
also supports the importance of this loop in AmyNSAR by providing similar 502 
interactions to different substrates, which can accommodate in a slight different 503 
orientation into the active site (Figure 6) [83]. 504 
 505 
The NSAR reaction involves a two-base 1,1-proton transfer mechanism, which differs 506 
from the one-base syn dehydration of the OSBS reaction
5
 [78]. Racemization of NxAs 507 
occurs via the base-catalyzed abstraction of the R-proton of the substrate by Lys163 to 508 
form a cation-stabilized enediolate anion intermediate; this intermediate is diverted to 509 
product with the assistance of an active site acid, which inserts the S-proton (Lys263) 510 
(Figure 7) [54,78]. In the opposite direction of the reaction, Lys263 would behave as the 511 
base, and Lys163 as the acid. QM/MM studies support this mechanism [83]. Whereas 512 
the catalytic framework is highly conserved in the whole enolase superfamily [77], 513 
comparison of structural elements related to the activity of the different members of this 514 
superfamily, including the 20s and 50s loops, revealed a lower conservation. Despite 515 
these regions might support in determining the substrate specificity of different 516 
superfamily members, this feature does not appear universal for the whole family 517 
[70,71]. The 20s loop of different members of the enolase superfamily is a highly 518 
variable element in the evolution of the superfamily; this loop is not present in some 519 
members of the superfamily, and it shows no flexibility in other enzymes [70]. 520 
However, in the context of the NSAR/OSBS subfamily, the 20s loop has been 521 
experimentally shown to play a role in the activity of the enzyme, and possibly to its 522 
                                                          
5
 A different mechanism is experimentally supported for the OSBS reaction. The reader is referred to [78] 
for further information.  
specificity in two different ways. Firstly, by hydrophobic interactions of Phe19 with 523 
both NSAR and OSBS substrates. Secondly, through interactions between surface 524 
residues of the 20s loop and residues in the cap domain that seem to set this loop into 525 
the closed configuration [71]. These observations reflect the essential character of the 526 
catalytic framework in the common strategy in formation of an enolic intermediate in 527 
the enolase superfamily (Figure 1), and concomitantly support the divergent evolution 528 
of the superfamily from a putative common ancestor into functionally distinct enzymes 529 
by variations in structural elements such as the 20s loop [54].  530 
 531 
 532 
Figure 7. Proposed reaction mechanism for NSAR. Adapted from [54 and 78].  533 
 534 
Mutation of specific residues at the region of the enzyme where the N-protecting group 535 
of the AA binds generated new interactions improving the kcat of the mutated enzyme 536 
for different NAAs (2-5 fold), with just slight variations in KM (mutant G291D/F323Y) 537 
[75,76]. This improvement could be explained as a result of new interactions generated 538 
by both mutations, mimicking the interactions known to occur between the succinyl-539 
group of the natural substrate and the protein. Another interesting structural aspect 540 
determined by Glasner’s group is the relevance of the Tyr299 residue in the evolution of 541 
OSBS towards NSAR activity [74]. They were able to “evolve” the activity of 542 
AacOSBS, lacking NSAR activity, to accept NS-Phegly as substrate by generating a 543 
Y299I mutation. They also showed the existence of epistatic constraints, which would 544 
complicate even more the structural basis for the determinants governing NSAR 545 





Protein engineering / enzyme immobilization  551 
 552 
The plausible link between catalytic promiscuity and evolvability converts the enolase 553 
superfamily, in principle, into a good toolbox for protein engineering due to its 554 
functional diversity and partially conserved chemical reaction [84,85]. A previous study 555 
showed different active-site mutants of E. coli OSBS with no detectable activity, but 556 
with substantially increased thermal stability [86]. The authors concluded that the 557 
results obtained were potentially important with regard to protein design and 558 
engineering, since mutants E190A and 3KDED could potentially be used as platforms 559 
for protein engineering in (β/α)8-barrels [86]. In the case of NSAR/OSBS, cysteine 560 
mutants have been engineered to enhance the enzyme thermal stability by formation of 561 
inter- (A68C-D72C and P60C-Y100C) and intra-S-S bonds (E149C-A182C and 562 
V265C). Whereas an increase of the Tm could be obtained, the activity was slightly to 563 
moderately affected, except for the A68C-D72C variant, which showed similar kcat/KM 564 
ratios to the wild type [87]. Engineering of AmyNSAR was achieved by relying on an 565 
in vivo selection system that linked the viability of an E. coli L-methionine auxotroph to 566 
the activity of the improved enzyme, using a simple colorimetric methodology: an 567 
evolved G291D/F323Y variant was obtained with up to 6-fold higher activity compared 568 
to the wild-type on a range of NAAs [75,76]. The G291D/F323Y variant was coupled 569 
with an enantiospecific D-acylase allowing a preparative DKR process for the 570 
production of optically pure D-allylglycine [75]. While not intended to specifically 571 
improve the catalytic activity of NSAR, a systematic mutagenesis study was conducted 572 
on the 20s loop of AmyNSAR and other binding-residues [71]. AmyNSAR mutants 573 
P18A, S22R, E165R, D140R/E165R or R20E/D140R/E165R resulted in slightly higher 574 
catalytic efficiencies when using the OSBS reaction. On the other hand, only F23A, 575 
E165R and R20E/D140R/E165R slightly increased the NSAR catalytic efficiency [71]. 576 
Special attention needs to be paid to these positions, since the original work reported 577 
expression problems with some of these protein variants [71]. As it has been mentioned 578 







) [74].  580 
 581 
Some efforts have also been carried out to study the immobilization of NSARs 582 
[63,67,88,89]. Enzyme immobilization resulted in a 75% loss of GkaNSAR activity [67] 583 
and 90 % with immobilized DraNSAR [63] when compared to the enzymes in solution. 584 
On the other hand, DraNSAR maintained full activity after 40 reaction cycles [63], and 585 
over 75 % of the activity remained after ten reactions cycles using GkaNSAR [67]. 586 
Despite slight changes/improvements in reaction temperature and thermal stability 587 
[63,67], we cannot determine whether immobilization is a cost-effective protocol. 588 
 589 
Biotechnological applications of NxAR enzymes 590 
Despite the limited number of NxAR enzymes discovered so far, the racemase activity 591 
of these enzymes is widely reported in different DKR processes in the literature. A 592 
considerable number of patents have been developed by important industrial companies 593 
about the use of NSAR for the production of optically pure amino acids (Table 1). 594 
These compounds are of economic interest, since they are used as additives in animal 595 
and human foodstuffs, in the pharmaceutical and cosmetics industries, and as chiral 596 
synthons in organic synthesis [50,52]. Extensive knowledge on the synthesis of racemic 597 
mixtures of amino acids is available (the Strecker reaction represents one of the simplest 598 
and most economical methods for the preparation of α-amino acids), and there are also a 599 
vast number of methods for the production of many different NxAs [e.g. 600 
57,63,64,66,71]. However, these enzymes have also found application in the production 601 
of some oxy-functionalized amino acids, widening their biotechnological application 602 
[37,90, Hibi et al, 2017 unpublished results].  603 
From the industrial point of view, it is advisable to bear into mind that Amycolatopsis 604 
orientalis sub. sp. lurida and AmyNSAR were initially reported to suffer substrate 605 
(NAA)/product inhibition [18,51,52]. Despite this drawback, May et al. suggested that 606 
the substrate inhibition observed for NSAR from Amycolatopsis orientalis sub. sp. 607 
lurida might be overcome [50]. Furthermore, substrate inhibition of AmyNSAR was 608 
afterwards suggested to be due to the lack of control of the pH [43], and it is reported to 609 
be active with 300 mM substrate at pH 8 [75]. In our own experience, GkaNSAR was 610 
not inhibited in the presence of substrate concentrations up to 0.5 M [66,67]. Thus, due 611 
to the differences found in the literature, inhibition at high concentrations of 612 
substrate/product should be assayed with new systems for commercial applications.  613 
Acylase / amidohydrolase process. 614 
Coupling of an NSAR with an L-acylase (E.C. 3.5.1.4) converted the original “acylase 615 
process” into a general DKR methodology extensively described for the production of 616 
optically pure L-amino acids starting from inexpensive D,L-NAA precursors [e.g. 617 
15,16,45,49,50,61] (Figure 8A). The tandem NSAR/D-acylase (E.C. 3.5.1.81) has also 618 
been experimentally demonstrated (Figure 8A) [21,49,75]. Although NAAs have been 619 
the most used substrates with the acylase process, it was early highlighted that other 620 
NxAs could also be used as substrates (see Table 3). Since i) several enantioselective or 621 
stereospecific amidohydrolases (NxAH) are available under E.C. 3.5.1 group, and ii) 622 
some of them have also exhibited a broad substrate spectrum, coupling of an NSAR 623 
with one of these enzymes would theoretically allow production of D- or L-amino acids 624 
starting from many different NxAs (Figure 8A). The “amidohydrolase process” [66] 625 
would be a more general nomenclature to refer to all the different NSAR/NxAH tandem 626 
enzyme combinations leading to the production of D- or L-amino acids starting from 627 
several NxAs. The NSAR/L-succinylase tandem (Figure 2, lower panel; Figure 8A) 628 
described in the D- to L-amino acid conversion pathway [57] has been described in 629 
several patents [e.g., 28,29,34,36,38]. In fact, the catalytic efficiencies of L-succinylase 630 








, similar to the catalytic efficiency observed for 631 
NSARs for the same substrates (Table 4) [57]. Additional enzymatic tandems are the 632 
NSAR/L-carbamoylase (E.C. 3.5.1.87) [62,63,66,67,91] or NSAR/D-succinylase 633 
[39,40,79,80] (Figure 8A). We previously demonstrated the conversion of NCAAs and 634 
NFAAs into the corresponding optically pure L-amino acids, with a productivity of 16 635 
mmol L-norleu L−1·h−
1
 (yield >99 %; e.e. 99.5 %), showing no inhibition at high 636 
concentrations of substrate or product using immobilized NSAR/L-carbamoylase; 0.5 M 637 
of racemic NF-aminobutyric acid could be converted in 85 hours [66,67]. Furthermore, 638 
GKaNSAR showed full activity after incubation at 45 ºC for 24 hours [66]. Most 639 
noticeably, the use of NF-AAss with an NSAR/L-carbamoylase tandem resulted in an 640 
unexpected higher conversion than with the use of NAAs or NCAAs, showing catalytic 641 









 for NFAAs. These results showed that substrate selection is an important 643 
parameter to be considered for the design of a NSAR/tandem enzyme combination, 644 
since the efficiencies achieved are comparable to the natural NSA substrates.  645 
Although we might have missed experimental evidence in the literature, an additional 646 
exploitable enzymatic system is the NSAR/D-carbamoylase (E.C. 3.5.1.77) tandem 647 
[91]. As we demonstrated previously, using alternative NxA substrates unexpectedly 648 
increased the yield of the NSAR/L-carbamoylase tandem (with NFAAs) [66,67]; since 649 
other NxAs are known to be substrates for NSARs (see Table 3), coupling with 650 
stereospecific NxAH recognizing other NxAs could produce alternative amidohydrolase 651 
systems with a higher potential to those known to date. Furthermore, the different 652 
solubility of substrate/products of the reaction can also be exploited to obtain the 653 
product of the reaction in situ (e.g., L-homophenylalanine), greatly reducing the cost of 654 
operation.  655 
 656 
Expanding the use of the amidohydrolase process  657 
Taking advantage of natural metabolic reactions, substrate promiscuity or engineered 658 
enzymes, methods can be evolved towards new substrate or products by inclusion of 659 
new enzymes. In this sense, enzyme modification of the amino acids produced by any 660 
of the possible NSAR/NxAH tandems described above is feasible. Hydroxylation of 661 
AAs or NSAs are among the numerous theoretical possibilities [92,93]. 2-Oxoglutarate-662 
dependent oxygenases are a family of enzymes catalysing various different reactions 663 
during the biosynthesis of many secondary metabolites, including hydroxylation, 664 
dealkylation, desaturation, epoxidation, epimerization, cyclization, and halogenations. 665 
Industrially, this class of enzymes has been used mainly for the derivatization of amino 666 
acids and in the biosynthesis of antibiotics [94]. A multi-enzymatic cascade expanding 667 
the established NSAR/L-acylase process has been proposed for the stereoselective 668 
production of γ-oxyfunctionalyzed amino acids [90] (Figure 8B). Coupling of this 669 
system with a stereoselective isoleucine dioxygenase from Bacillus thuringiensis results 670 
in a new approach for the production of L-methionine-(S)-sulfoxide and different γ-671 
hydroxy amino acids [90]. Another interesting approach has been presented by Ogawa’s 672 
group. Taking advantage of the NSAR/D-succinylase system, inclusion of an N-673 
succinyl-L-leucine 3-hydroxylase allowed the production of several aliphatic (2R)-3-674 
hydroxyamino acids with high optical activity (Figure 8C). (2R,3R)-3-hydroxyleucine 675 
was successfully produced from N-succinyl-L-leucine [Hibi et al, 2017 (unpublished 676 




Figure 8. Different enzymatic methodologies where NSARs can be applied. A) General 681 
scheme on the amidohydrolase process (D-system, dashed line; L-system, full line). 682 
NxAH: N-substituted stereospecific amidohydrolase. R=Acyl, NSAR/Acylase tandem 683 
(original acylase process); R=carbamoyl, NSAR/carbamoylase tandem; R=formyl, 684 
NAAR/carbamoylase tandem. R=succinyl, NSAR/Succinylase tandem. B) 685 
Stereoselective production of γ-oxyfunctionalyzed amino acids. L-ACYL, L-686 
aminoacylase from Geobacillus thermoglucosidasius. BtDO: stereoselective isoleucine 687 
dioxygenase from Bacillus thuringiensis [90]. C) Enantioselective synthesis of 688 
enantioenriched (2R)-3-hydroxyamino acids [Hibi et al 2017, unpublished results]. 689 
SadA: N-succinyl-L-amino acid 3-hydroxylase from Burkholderia ambifaria AMMD; 690 
D-SUC: N-succinyl-D-amino acid desuccinylase from Cupriavidus sp. P4-10-C. D) 691 
Modified hydantoinase process (D-system, dashed line; L-system, full line). HR*: 692 
hydantoin racemase (or chemical racemization when favored); D-CAR: D-693 
carbamoylase; DH, D-activity of hydantoinase; L-CAR: L-carbamoylase; LH, L-activity 694 
of hydantoinase [88,91].  695 
Modification of the hydantoinase process  696 
The hydantoinase process is a cheap and environment-friendly method for the potential 697 
production of any optically pure amino acid from a wide spectrum of D,L-5-698 
monosubstituted hydantoins. Its main application is the production of optically pure D-699 
amino acids, as most hydantoinases/dihydropyrimidinases exhibit clear D-700 
enantioselectivity [91,95]. Production of L-amino acids with this system is also possible 701 
using the “residual” or engineered L-activity of hydantoinases together with an L-702 
specific carbamoylase [95,96]. As demonstrated in the patents by Bommarius et al. 703 
(Evonik industries [17]), coupling of an NSAR together with a D-hydantoinase and an 704 
L-carbamoylase allows the racemization of the D-NCAA produced by hydantoinase, 705 
producing L-NCAA in the reaction medium, which can be then hydrolyzed by the L-706 
carbamoylase to the corresponding L-amino acid. The HYD/NSAR/LCAR system has 707 
been further exploited [97] and expanded by inclusion of a fourth enzyme, hydantoin 708 
racemase, which speeds up the process by racemization of the remaining L-5-709 
monosubstituted hydantoin for substrates whose chemical racemization is not favored 710 
[88,89,98] (Figure 8D). 711 
Conclusions 712 
The increasing demand for non-natural amino acids makes NSAR an interesting 713 
candidate for biotechnological applications, despite the initial drawbacks reported on 714 
substrate/product inhibition. The use of racemases allows DKR of cheap substrates, an 715 
important parameter of industrial interest. Economic aspects of enzyme production, 716 
substrate synthesis and/or operational costs can drive the feasibility of different 717 
NSAR/tandem enzyme combinations. The substrate promiscuity of NSAR and the other 718 
enzymes participating in enzyme cascades together with a NSAR (such as the 719 
amidohydrolase process) opens up new opportunities in NSAR-based technology for the 720 
production of optically pure amino acids and enriched hydroxyl-amino acids. The 721 
increasing number of applications appearing in the literature reflects the interest on this 722 
enzyme, and the newly implemented NSAR/succinylase methodologies predict new 723 
strategies in the forthcoming years. Thus, isolation of new NSAR enzymes with 724 
different substrate specificities, improved activity, or higher stability continues to be of 725 
great biotechnological interest. Since i) NSAR enzymes have been successfully 726 
produced recombinantly, and ii) the prices of synthetic genes nowadays is low, a semi 727 
high-throughput approach by cloning, expression and activity analysis of different 728 
members of the OSBS/NSAR superfamily is a plausible method to find new and 729 
efficient NSAR enzymes. If a sequence-based strategy is intended to find new NSAR 730 
enzymes with potential biotechnological application, two relevant aspects should be 731 
contemplated. Firstly, conservation of residues involved in NSAR activity need to be 732 
ascertained before selection [71,74]. Secondly, searching for similar 733 
“M20/GNAT/NSAR’’ genetic organizations is advisable for new NSAR identification 734 
[57,58,68] (Figure 2). Bioinformatics tools for sequence similarity and genome 735 
neighborhood networks are freely available to help in this task for neophyte in the in 736 
silico field [99,100].  737 
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